[HTML][HTML] Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials
IM Proença, JR Allegretti, WM Bernardo… - Nutrition research, 2020 - Elsevier
Obesity and metabolic syndrome are important health problems that can lead to significant
morbidity/mortality as well as subsequent health concerns. Alterations in the gut microbiota
have been implicated in both obesity and metabolic syndrome. Fecal Microbiota
Transplantation (FMT) has emerged as a new promising therapeutic approach aimed at
manipulating the gut microbiota in various chronic diseases. Randomized clinical trials
assessing the use of FMT in obese and metabolic syndrome patients have been reported …
morbidity/mortality as well as subsequent health concerns. Alterations in the gut microbiota
have been implicated in both obesity and metabolic syndrome. Fecal Microbiota
Transplantation (FMT) has emerged as a new promising therapeutic approach aimed at
manipulating the gut microbiota in various chronic diseases. Randomized clinical trials
assessing the use of FMT in obese and metabolic syndrome patients have been reported …
